Pharmaceuticals & Life Sciences Articles & Blogs

Articles & Blogs Pharma & Life Sciences

Cell and Gene Therapy Catapult Publishes National Cell and Gene Therapy Vision

Wednesday, 06 April 2022

The UK's Cell and Gene Therapy Catapult has published a new National Cell and Gene Therapy Vision.

Cell and Gene Therapy Catapult Publishes National Cell and Gene Therapy Vision

Articles & Blogs Pharma & Life Sciences

£60m of New UK Funding for Life Sciences Innovation Manufacturing

Wednesday, 06 April 2022

£60 million of funding is being made available to support commercial-scale manufacturing by life sciences businesses companies that are at the leading-edge of innovation.

£60m of New UK Funding for Life Sciences Innovation Manufacturing

Articles & Blogs Pharma & Life Sciences

UK Immigration Reforms - Routes to Consider for Pharmaceutical Businesses Attracting Talent from Overseas

Friday, 01 April 2022

In December 2020 changes were made to the UK's Immigration Rules introducing the Government's new, post-Brexit, points-based system.

UK Immigration Reforms - Routes to Consider for Pharmaceutical Businesses Attracting Talent from Overseas

NHS in Yet Another Negotiated Discounted Deal for Game-Changing Libmeldy Drug

Friday, 11 March 2022

NHS England has agreed another deal for a costly 'game-changing' drug. Orchard Therapeutics usually supplies its Libmeldy gene therapy drug for £2.8m, the most expensive in the world.

NHS in Yet Another Negotiated Discounted Deal for Game-Changing Libmeldy Drug

Articles & Blogs Pharma & Life Sciences

Government Publishes Rare Diseases Action Plan

Tuesday, 01 March 2022

The Government has published the first action plan to show how the Department of Health and Social Care and its delivery partners will implement the UK Rare Diseases Framework in England.

Government Publishes Rare Diseases Action Plan

Articles & Blogs Pharma & Life Sciences

Delivery Time Deemed to Be 'of the Essence' in Informal Contract

Tuesday, 01 March 2022

Phrases are commonly used in agreements such as 'time is of the essence,' but what do they mean? And what happens if the contract is silent?

Delivery Time Deemed to Be 'of the Essence' in Informal Contract

Articles & Blogs Pharma & Life Sciences

MHRA Provides Guidance for Medicine Suppliers Supplying to Northern Ireland

Monday, 07 February 2022

The Medicines and Healthcare products Regulatory Agency (MHRA) is providing a series of guidance to help medicines suppliers to grapple with supplying into Northern Ireland (NI).

MHRA Provides Guidance for Medicine Suppliers Supplying to Northern Ireland

Articles & Blogs Pharma & Life Sciences

High Court Allows COVID-19 Force Majeure Termination - After Disputes Over Who Was 'Affected'

Monday, 07 February 2022

COVID-19 has caused massive disruption to business, and common clauses in contracts have been considered afresh to deal with the situation.

High Court Allows COVID-19 Force Majeure Termination - After Disputes Over Who Was 'Affected'

Articles & Blogs Pharma & Life Sciences

NICE Launches New Flexible Assessment Methods

Wednesday, 02 February 2022

The National Institute for Health and Care Excellence (NICE) has launched a new approach to how it assesses medicines and other health technologies. It aims to provide NHS patients with earlier access to innovative treatments.

NICE Launches New Flexible Assessment Methods

Articles & Blogs Pharma & Life Sciences

Parallel Imports Into the UK: No Change to the Law Yet

Wednesday, 02 February 2022

The UK Intellectual Property Office (UK IPO) has published the results of its consultation on the UK's future exhaustion regime for intellectual property rights (IPR).

Articles & Blogs Pharma & Life Sciences

Cell and Gene Therapy Catapult and Deep Science Ventures Enter Exciting Collaboration

Wednesday, 12 January 2022

The Cell and Gene Therapy (CGT) Catapult and Deep Science Ventures (DSV) are collaborating to create a novel approach to overcoming barriers and boost innovation in the pioneering area of Advanced Therapy Medicinal Products (ATMPs).

Cell and Gene Therapy Catapult and Deep Science Ventures Enter Exciting Collaboration

The Risk of Opioids to UK Pharmacy

Monday, 10 January 2022

Amidst the swell of litigation surrounding the opioid crisis in the US, the ripples of a court decision against the three largest pharmacy chains are being felt across the pond.

Articles & Blogs Pharma & Life Sciences

Solution Found for Northern Ireland Medicines Supply Issues

Monday, 20 December 2021

A major issue facing the pharma supply chain across the UK in 2021 has been the impact of the Northern Ireland (NI) Protocol and what this means for the ability to supply medicines to patients in NI.

Solution Found for Northern Ireland Medicines Supply Issues

Articles & Blogs Pharma & Life Sciences

NHS Sets Net Zero Roadmap of Requirements From Suppliers

Monday, 13 December 2021

With the UK recently hosting COP26, NHS England and Improvement has provided a roadmap for what it requires from suppliers to work towards net zero. Meanwhile some of the biggest suppliers to the NHS have joined forces to pledge to reach net zero by 2045.

NHS Sets Net Zero Roadmap of Requirements From Suppliers

Articles & Blogs Pharma & Life Sciences

Data Sharing in Health Care Research and Innovation - How Is Our Data Being Used?

Monday, 13 December 2021

How to use health data is a hot topic in health care research and innovation, with crucial questions around how to best utilise health data while still complying with data subject rights and maintaining public trust.

Data Sharing in Health Care Research and Innovation - How Is Our Data Being Used?

Pharma & Life Sciences

Share this page: